Naples, Italy

Aldo Mancini

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Aldo Mancini: Innovator in Cancer Treatment

Introduction

Aldo Mancini is a notable inventor based in Naples, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments for cancer. With a total of 3 patents, his work focuses on utilizing proteins and peptides to combat diseases related to free radicals.

Latest Patents

Mancini's latest patents include "Manganese superoxide dismutase variants and uses thereof." This invention concerns variant proteins of manganese superoxide dismutase (MnSOD) and their applications in treating or preventing tumors. The invention highlights a short variant of recombinant MnSOD, which can be used for addressing diseases associated with an excess of free radicals. Another significant patent is "Peptides and their use as carriers into cancer cells." This patent describes the use of a peptide as a carrier for transporting molecules or radioisotopes into cancer cells, along with modifications of the peptide for enhanced efficacy.

Career Highlights

Throughout his career, Aldo Mancini has worked with various organizations, including the Italian Space Agency (Agenzia Spaziale Italiana). His experience in these institutions has contributed to his expertise in biotechnology and cancer research.

Collaborations

Due to space constraints, the details of collaborations will not be included.

Conclusion

Aldo Mancini's innovative work in the field of cancer treatment through his patented inventions showcases his dedication to advancing medical science. His contributions are paving the way for new therapeutic approaches in combating cancer and related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…